Nektar Therapeutics

Agios Pharmaceuticals Inc, based in San Mateo, CA, is a pioneering leader in the field of cellular metabolism, dedicated to developing innovative therapies for patients with rare diseases such as pyruvate kinase deficiency, thalassemia, and sickle cell disease. By prioritizing patient needs and fostering collaborative relationships with healthcare professionals and patient communities, Agios aims to create impactful, disease-modifying therapies that address unmet medical needs. Founded on the principles of scientific excellence and community engagement, Agios cultivates a supportive and flexible work environment that empowers its employees to contribute their best. This commitment to culture and collaboration drives the company's ongoing success in advancing groundbreaking treatments for those affected by rare diseases. Generated from the website

Eiger Biopharmaceuticals is a research-driven biopharmaceutical company based in Palo Alto, CA. The company focuses on developing innovative therapies for serious diseases with unmet medical needs. Utilizing cutting-edge technology and scientific expertise, Eiger Biopharmaceuticals is dedicated to advancing novel treatments to improve patient outcomes and quality of life. Generated from their business information

MicuRx Pharmaceuticals, Inc is a global biopharmaceutical company headquartered in Shanghai, with branches in California, Hong Kong, and Beijing. Founded in 2007, they are committed to discovering, developing, and delivering innovative medicines that address unmet clinical needs, particularly in the field of antibiotic resistance and kidney disease. With a focus on the design, discovery, and development of novel drugs for infectious diseases and unmet medical needs, MicuRx aims to target drug-resistant bacterial infections and provide the next generation of safe and effective antibiotics.Generated from the website